RBC Capital Reiterates Outperform on Eli Lilly, Maintains $1500 Price Target

RBC Capital analyst Trung Huynh has reiterated an Outperform rating on Eli Lilly (NYSE: LLY) and has maintained a price target of $1500 for the stock. This indicates a positive outlook for the company's performance in the market.